Efficacy and safety of delgocitinib in treating chronic hand eczema: A systematic review and meta-analysis of randomized controlled trials
Background: Chronic hand eczema (CHE) is a persistent inflammatory skin condition that is often difficult to manage and associated with substantial functional impairment and reduced quality of life. Delgocitinib, a topical pan-Janus kinase inhibitor, has emerged as a potential nonsteroidal therapeut...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
SAGE Publishing
2025-12-01
|
| Colección: | Proceedings of Singapore Healthcare |
| Acceso en línea: | https://doi.org/10.1177/20101058251409425 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|